Publications by authors named "Michael Grunwald"

Claim this Profile
A
Allogeneic haematopoietic cell transplantation in advanced systemic mastocytosis in the new era: A CIBMTR study.
Celalettin Ustun, Mei-Jie Zhang, Andrew Peterson, Alexander Baek, Mounzer Agha, Michael Grunwald

Br J Haematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomics of Acute Myeloid Leukemia at Diagnosis and Remission.
Kai Yu, Laura W Dillon, Jesse M Tettero, Gege Gui, Rasha W Al-Ali, Michael R Grunwald

medRxiv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distress and Care Utilization in Patients with Myeloproliferative Neoplasms.
Rushil Patel, Rushil Virendra Patel, Danielle Boselli, Patrick L Meadors, Stephanie Begley, Michael R Grunwald

Acta Haematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation.
Stephanie J Lee, Brent Logan, Mary M Horowitz, Jason G Dehn, Joseph Pidala, Michael R Grunwald

J Clin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: BMT CTN 1702 Trial.
Jason G Dehn, Brent Logan, Stephanie J Lee, Bronwen E Shaw, Steven Devine, Michael R Grunwald

Transplant Cell Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updates on Therapy Options in Fit and Unfit Patients with Newly Diagnosed AML.
Gray H Magee, Michael R Grunwald

Curr Treat Options Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transplant outcomes using older matched sibling donors compared with young alternative donors: a CIBMTR analysis.
Karthik Nath, Mei-Jie Zhang, Matthew Bye, Muhammad Bilal Abid, Cara Benjamin, Michael R Grunwald

Blood Adv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Review of Real-World Experience With Ruxolitinib for Myelofibrosis.
Haifa Kathrin Al-Ali, Aaron T Gerds, Michael R Grunwald, Jingbo Yu

Clin Lymphoma Myeloma Leuk· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor Type Does Not Impact Late Graft Failure Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis.
Cindy Lynn Hickey, Mei-Jie Zhang, Mariam Allbee-Johnson, Rizwan Romee, Navneet S Majhail, Michael R Grunwald

Transplant Cell Ther· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venous Thromboembolism Incidence and Risk Factors in Patients Undergoing Hematopoietic Stem Cell Transplantation.
Miranda Benfield, Jiaxian He, Justin Arnall, Whitney Kaizen, Elizabeth Jandrisevits, Michael R Grunwald

Transplant Cell Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Molecular MRD testing in patients with acute myeloid leukemia.
Amanda L Blackmon, Michael R Grunwald

Bone Marrow Transplant· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biologically Randomized Comparison of Haploidentical Versus Human Leukocyte Antigen-Matched Related Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.
Michael R Grunwald, Wei Sha, Jiaxian He, Srinivasa Sanikommu, Jonathan M Gerber

Transplant Cell Ther· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: An Interventional Trial.
Jason G Dehn, Brent Logan, Bronwen E Shaw, Steven Devine, Stefan O Ciurea, Michael R Grunwald

medRxiv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematocrit control and thrombotic risk in patients with polycythemia vera treated with ruxolitinib in clinical practice.
Aleksander Chojecki, Danielle Boselli, Allison Dortilus, Issam Hamadeh, Stephanie Begley, Michael Richard Grunwald

Ann Hematol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study.
Tania Jain, Noel Estrada-Merly, M Queralt Salas, Soyoung Kim, Jakob DeVos, Michael R Grunwald

Blood Adv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment comparison of hydroxyurea versus ruxolitinib in essential thrombocythaemia: A matched-cohort analysis.
Michael R Grunwald, Ellen K Ritchie, Elisa Rumi, Albert Assad, J E Hamer-Maansson

EJHaem· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between elevated white blood cell counts and thrombotic events in polycythemia vera: analysis from REVEAL.
Aaron T Gerds, Ruben Mesa, John M Burke, Michael R Grunwald, Brady L Stein

Blood· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration.
Tania Jain, Hua-Ling Tsai, Hany Elmariah, Pankit Vachhani, Theodoros Karantanos, Michael R Grunwald

Haematologica· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Top advances of the year: Myeloproliferative neoplasms.
Rupali R Bhave, Ruben Mesa, Michael R Grunwald

Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis.
Hemant S Murthy, Mei-Jie Zhang, Karen Chen, Sairah Ahmed, Uday Deotare, Michael R Grunwald

Blood Adv· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetic and clinical predictors of voriconazole concentration in hematopoietic stem cell transplant recipients receiving CYP2C19-guided dosing.
Jai N Patel, Myra Robinson, Sarah A Morris, Elizabeth Jandrisevits, Karine Eboli Lopes, Michael R Grunwald

Pharmacogenomics J· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of pentamidine tolerability and efficacy between phenotypes.
Alexis Koon, Jiaxian He, Jai Patel, Allison Morse, Victoria Boseman, Michael Grunwald

Pharmacogenomics· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardising acute myeloid leukaemia classification systems: a perspective from a panel of international experts.
Rory M Shallis, Naval Daver, Jessica K Altman, Rami S Komrokji, Daniel A Pollyea, Michael R Grunwald

Lancet Haematol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transplantation and cellular therapy in acute leukemia.
Michael Grunwald, Belinda Avalos, Edward Copelan

Best Pract Res Clin Haematol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temperature-Responsive Nanoporous Membranes from Self-Assembly of Poly(-isopropylacrylamide) Hairy Nanoparticles.
Yulia Eygeris, Qiaoyi Wang, Marion Görke, Michael Grünwald, Ilya Zharov

ACS Appl Mater Interfaces· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis